✦ LIBER ✦

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

✍ Scribed by Hotta, Katsuyuki; Suzuki, Etsuji; Di Maio, Massimo; Chiodini, Paolo; Fujiwara, Yoshiro; Takigawa, Nagio; Ichihara, Eiki; Reck, Martin; Manegold, Christian; Pilz, Lothar; Hisamoto-Sato, Akiko; Tabata, Masahiro; Tanimoto, Mitsune; Shepherd, Frances A.; Kiura, Katsuyuki

Book ID: 119320977
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 475 KB
Volume: 79
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.10.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors affecting the association betwee

Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

✍ Aboshi, Masayuki; Kaneko, Masayuki; Narukawa, Mamoru 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 339 KB

Clinical significance of SOX9 in human n

Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival

✍ Chun-Hui Zhou; Li-Ping Ye; Shi-Xing Ye; Yan Li; Xin-Yin Zhang; Xin-Yu Xu; Li-Yun 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 407 KB

Individual-level data on the relationshi

Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy

✍ Hisao Imai,Keita Mori,Akira Ono,Hiroaki Akamatsu,Tetsuhiko Taira… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 213 KB

Determinants of Survival in Advanced Non

Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies

✍ Bauml, Joshua; Mick, Rosemarie; Zhang, Yu; Watt, Christopher D.; Vachani, Anil; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 807 KB

Circulating tumour cells early predict p

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents

✍ Tol, J.; Koopman, M.; Miller, M. C.; Tibbe, A.; Cats, A.; Creemers, G. J. M.; Vo 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 327 KB

Evaluating the Impact of Bevacizumab Mai

Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non–Small-Cell Lung Cancer

✍ Dranitsaris, George; Beegle, Nancy; Ravelo, Arliene; Kalberer, Traci; Yu, Elaine 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 430 KB